Annual report pursuant to Section 13 and 15(d)

Balance Sheets

v3.21.1
Balance Sheets - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current Assets:    
Cash and cash equivalents $ 4,401,114 $ 6,777,052
Prepaid research and development 233,035 536,916
Prepaid expenses and other current assets 501,689 359,499
Total Current Assets 5,135,838 7,673,467
Intangible assets, net 5,606 6,170
Advance to seller 350,000
Total Assets 5,491,444 7,679,637
Current Liabilities:    
Accounts payable 648,739 190,204
Accrued expenses 856,639 348,847
Total Current Liabilities 1,505,378 539,051
Commitments and contingencies  
Stockholders’ Equity    
Preferred Stock, 5,000,000 shares authorized with a par value of $0.001 per share, 0 shares outstanding at December 31, 2020 and 2019
Common Stock, 50,000,000 shares authorized with a par value of $0.001 per share, 14,393,100 and 10,368,352 shares issued and outstanding at December 31, 2020 and 2019, respectively 14,393 10,368
Additional paid in capital 35,491,462 27,757,017
Accumulated deficit (31,519,789) (20,626,799)
Total Stockholders’ Equity 3,986,066 7,140,586
Total Liabilities and Stockholders’ Equity $ 5,491,444 $ 7,679,637